BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia

Chronic myeloid leukemia (CML) is induced by the oncogenic BCR-ABL1 tyrosine kinase and can be effectively treated for many years with tyrosine kinase inhibitors (TKIs). However, unless CML patients receive life-long TKI treatment, leukemia will eventually recur; this is attributed to the failure of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurtz, Christian, Hatzi, Katerina, Cerchietti, Leandro, Braig, Melanie, Park, Eugene, Kim, Yong-mi, Herzog, Sebastian, Ramezani-Rad, Parham, Jumaa, Hassan, Müller, Martin C., Hofmann, Wolf-Karsten, Hochhaus, Andreas, Ye, B. Hilda, Agarwal, Anupriya, Druker, Brian J., Shah, Neil P., Melnick, Ari M., Müschen, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2011
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201200/
https://www.ncbi.nlm.nih.gov/pubmed/21911423
http://dx.doi.org/10.1084/jem.20110304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201200/
https://www.ncbi.nlm.nih.gov/pubmed/21911423
http://dx.doi.org/10.1084/jem.20110304

Ejemplares similares